Conferences

GENOSKIN TO ATTEND 47TH ANNUAL ESDR MEETING 2017 Here at Genoskin, we’re pleased to announce our presence at the 47th Annual Meeting of the European Society for Dermatological Research (ESDR). The meeting will take place in Salzburg, Austria from September 27th to 30th, 2017. The ESDR aims to promote research in dermatology and skin biology and open up the dialogue between

Read more

Genoskin to attend Boston-Paris Biotechnology Summit In order to better serve our American customers, Genoskin plans to set up a production unit in Boston in 2018. Our project has recently been selected by the NETVA program, which helps companies  prepare for this strategic move. In May, we will attend the Boston-Paris Biotechnology Summit, an independent conference supported by a panel of biotech professionals from both sides of the

Read more

Every year, the MEDEF, France’s largest entrepreneurial organisation, sets up local conferences in an attempt to bring companies together under a predefined theme. This year, Genoskin was invited to the 7th Edition of the Entrepreneurial Event (Grande Tribune des Entrepreneurs) to contribute to the discussion on the role of CEOs in driving change. The widely attended conference was headed by Pierre Gataz, the MEDEF’s president (see

Read more

44th annual ESDR meeting, Copenhagen, Denmark     Genoskin will attend the 44th annual European Society for Dermatological Research meeting in Copenhagen, Denmark. The congress will take place from September 10 to September 13, 2014. The European Society for Dermatological Research (ESDR) aims to disseminate knowledge and facilitate exchange of information relevant to investigative dermatology between clinicians and scientists worldwide.Read more

Genoskin attended the 9th World Congress On Alternatives and Animal Use in The Life Sciences  (WC9 2014) organized in Prague, Czech Republic, from the 24 to the 28 August. “The world congress provides an exceptional forum to underline the importance of both the ethical issues of animal experimentation and the approach to the life sciences in the 21st century.”

Genoskin has presented its ex vivo human skin explant model, NativeSkin®, during labcourses focused on skin drug delivery and organized at the Bio Barrier 2014 congress in Saarbrücken, Germany.